Fibrolamellar hepatocellular carcinoma

被引:22
|
作者
Smith, Mitchell T. [1 ]
Blatt, Ellen R. [2 ]
Jedlicka, Paul [2 ]
Strain, John D. [2 ]
Fenton, Laura Z. [2 ]
机构
[1] Univ Colorado, Hlth Sci Ctr, Dept Radiol, Aurora, CO 80045 USA
[2] Childrens Hosp, Dept Radiol, Denver, CO 80218 USA
关键词
D O I
10.1148/rg.282075153
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
History A 13-year, 10-month-old boy presented with a low energy level, depression, and intermittent diarrhea. According to his growth chart, at age 7 years he was in the 25-50 percentile for height. At the time of presentation, he had fallen to the fifth percentile. Results of a bone age study indicated that his bone age, according to the standards of Gruelich and Pyle, was within 2 months of his chronologic age. Laboratory studies revealed the levels of free thyroxine and thyroid-stimulating hormone to be 12.6 pmol/L (normal range, 10.3-21.9 pmol/L) and 7.08 mIU/L (normal range, 0.36-5.4 uIU/mL), respectively. He began taking 50 mcg of Levothyroxine, which had a positive effect on his energy level. Results of physical examination at this time were remarkable for gynecomastia; the patient was referred for an endocrine evaluation. A month and a half later, the patient presented to the emergency department with shortness of breath and tachycardia. In addition, he experienced vomiting and diarrhea without fever over the previous 2 days. The patient's level of estrone was elevated at 777 pmol/L (normal range, 55.5-925 pmol/L), with estradiol at 8.1 pmol/L (normal range, 1.84-5.9), androstenedione at 2.2 nmol/L (normal range, 1.1-2.3), cortisol at 402.8 nmol/L (normal range, 140-690), and alpha-fetoprotein at 2.8 mu g/mL. Chest and abdominal computed tomography (CT) was ordered for a suspected pulmonary embolus and for liver abnormalities.
引用
收藏
页码:609 / 613
页数:5
相关论文
共 50 条
  • [41] A PLEOMORPHIC HEPATOCELLULAR-CARCINOMA WITH BIOCHEMICAL FEATURES OF FIBROLAMELLAR HEPATOCELLULAR-CARCINOMA
    BUAMAH, PK
    MCARDLE, P
    BENNETT, M
    JAMES, OFW
    LENDRUM, R
    JOURNAL OF SURGICAL ONCOLOGY, 1986, 32 (02) : 93 - 95
  • [42] Characterization of a novel mutation in fibrolamellar hepatocellular carcinoma
    Riggle, Kevin M.
    Kenerson, Heidi
    Kazami, Machiko
    Bauer, Renay
    Yeung, Raymond Sze
    Riehle, Kimberly J.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [43] Cell cycle biology of fibrolamellar hepatocellular carcinoma
    Dhingra, Sadhna
    Li, Wei
    Tan, Dongfeng
    Zenali, Maryam
    Zhang, Haizeng
    Brown, Robert E.
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2010, 3 (08): : 792 - 797
  • [44] A Rare Case of Fibrolamellar Variant Hepatocellular Carcinoma
    Zamora, Ernesto
    Sostre, Vanessa
    Kanagalingam, Gowthami
    Christopher, Ramos
    Arif, Muhammad Osman
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S1822 - S1822
  • [45] Fibrolamellar hepatocellular carcinoma: A rare but unpleasant event
    Abdelhamed, Walaa
    El-Kassas, Mohamed
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2022, 14 (06) : 1103 - 1114
  • [46] FAPI PET Positivity in Fibrolamellar Hepatocellular Carcinoma
    Suthar, Ritesh Ramesh
    Purandare, Nilendu
    Shah, Sneha
    Agrawal, Archi
    Puranik, Ameya
    Rangarajan, Venkatesh
    CLINICAL NUCLEAR MEDICINE, 2023, 48 (07) : E332 - E333
  • [47] Immunohistochemical detection of procalcitonin in fibrolamellar hepatocellular carcinoma
    Kotaro Matsumoto
    Kentaro Kikuchi
    Ayako Hara
    Hiromichi Tsunashima
    Koichi Tsuneyama
    Shinpei Doi
    Clinical Journal of Gastroenterology, 2021, 14 : 827 - 830
  • [48] Aggressive surgical management of fibrolamellar hepatocellular carcinoma
    Hemming, AW
    Langer, B
    Greig, PD
    Taylor, BR
    GASTROENTEROLOGY, 1996, 110 (04) : A1391 - A1391
  • [49] Fibrolamellar hepatocellular carcinoma with paraneoplastic neuropsychiatric manifestations
    Karam, Charbel
    Izhar-ul Haque
    Fewtrell, Miriam
    Das, Amitabha
    ANZ JOURNAL OF SURGERY, 2020, 90 (10) : 2114 - 2115
  • [50] Aggressive Surgical Management of Fibrolamellar Hepatocellular Carcinoma
    Hemming A.W.
    Langer B.
    Sheiner P.
    Greig P.D.
    Taylor B.R.
    Journal of Gastrointestinal Surgery, 1997, 1 (4) : 342 - 346